Nasal Spray – Talk Bio

Actionable Insights Powered by AI

J&J’s Spravato Surpasses $1 Billion in Revenue for 2024

3 months ago talkbio0Tagged 2024, J&J, Mental Depression, Nasal Spray, Spravato

J&J, Spravato, revenue, 2024, depression treatment, nasal spray

FDA Approves ARS’s Epinephrine Nasal Spray for Emergency Allergic Reactions

9 months ago talkbio0Tagged anaphylaxis, Approved, epinephrine, Epipen, Nasal Spray, needle-free alternative, SLURP1 gene, United States Food and Drug Administration

FDA approval, epinephrine nasal spray, ARS Pharmaceuticals, anaphylaxis treatment, needle-free alternative, EpiPen

Orexo’s Opioid Overdose Nasal Spray Fails FDA Review for Second Time

9 months ago talkbio0Tagged Drug Overdose, Homo sapiens, naloxone, Nasal Spray, Opioids, Orexo, OX124, Technical Data, Techniques, United States Food and Drug Administration

Orexo, OX124, FDA, Nasal Spray, Opioid Overdose, Naloxone, Human Factors Study, Technical Data